慢性鼻窦炎伴鼻息肉患者微生物-代谢物特征与糖皮质激素反应性相关
组织嗜酸性粒细胞计数是最强传统预测指标(AUC=0.885),多组学整合模型AUC=0.899仅轻微提升。
要点
- GC应答者基线组织嗜酸性炎症更重,非应答者NPS更高。
- 应答者基线富集Bacteroides caccae等菌种及lupinisoflavone N等代谢物。
- 组织嗜酸性粒细胞计数是GC反应性最强传统预测指标(AUC=0.885)。
核心结论
- 肠道微生物-血浆代谢组特征反映GC治疗的系统免疫代谢背景,与CRSwNP患者GC反应性相关,可解释个体间疗效差异。
研究设计与样本
- GC反应性定义为口服甲泼尼龙2周后内镜下NPS变化。
- 进行粪便鸟枪法宏基因组和非靶向血浆代谢组学分析。
主要发现
- 基线时GC应答者组织嗜酸性炎症显著更重,非应答者NPS更高。
- 应答者基线富集Bacteroides caccae、Microbacterium flavum和Mucilaginibacter rigui,以及lupinisoflavone N、CAY10622、kanzonol V和D-sorbitol显著升高。
- 上述基线特征与组织嗜酸性炎症正相关。
- 治疗后应答者Lund-Mackay CT总分、筛窦/上颌窦CT评分比、NPS、组织嗜酸性炎症及组织IL-6 mRNA水平下降显著更大。
- 组织嗜酸性粒细胞计数是最强传统预测指标(AUC=0.885),多组学整合模型AUC=0.899仅边际改善。
临床怎么用
- 基线组织嗜酸性粒细胞计数可用于预测CRSwNP患者对口服GC的反应性。
- 肠道微生物-血浆代谢组特征可能辅助解释GC疗效个体差异,但多组学模型预测增益有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) exhibit heterogeneous responses to oral glucocorticoids (GCs), but the biological basis of this variability remains unclear. OBJECTIVE: To identify gut microbiome‒plasma metabolomic signatures associated with GC responsiveness in CRSwNP patients and to compare their predictive value with that of conventional clinical indicators. METHODS: Patients with CRSwNP aged 18-65 years with bilateral nasal polyps and a nasal polyp score (NPS) ≥ 2 on at least one side were enrolled, together with septoplasty controls without sinonasal disease. GC responsiveness was defined as the change in endoscopic NPS after 2 weeks of oral methylprednisolone. Fecal shotgun metagenomic and untargeted plasma metabolomics were performed. RESULTS: Twenty-six CRSwNP patients and 30 controls were included. At baseline, GC responders had significantly greater tissue eosinophilic inflammation, whereas GC non-responders had higher NPS. Responders exhibited distinct baseline gut microbial and plasma metabolic profiles, characterized by the enrichment of Bacteroides caccae, Microbacterium flavum, and Mucilaginibacter rigui, and markedly elevated levels of lupinisoflavone N, CAY10622, kanzonol V, and D-sorbitol. These baseline features were positively correlated with tissue eosinophilic inflammation. After treatment, reductions in Lund-Mackay CT total score, ethmoid/maxillary sinus CT score ratio, NPS, tissue eosinophilic inflammation, and tissue IL-6 mRNA levels were significantly greater in GC responders. Tissue eosinophil count was the strongest conventional predictor (AUC = 0.885), while the integrated multiomics model achieved an AUC of 0.899, showing only marginal improvement. CONCLUSION: Gut microbiome-plasma metabolomic signatures capture the systemic immunometabolic context of GC therapy and are linked to GC responsiveness in CRSwNP, explaining interindividual treatment efficacy differences.
引用
- Zhang YY, Ding XY, Lu MP, et al. Microbial-Metabolite Signatures Are Associated With Glucocorticoid Responsiveness in Chronic Rhinosinusitis With Nasal Polyps. Int Forum Allergy Rhinol. 2026. PMID: 42637687. doi:10.1002/alr.70246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。